NUCLEOCYTOPLASMIC TRANSPORT OF THE REV PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS DEPENDENT ON THE ACTIVATION DOMAIN OF THE PROTEIN

被引:58
|
作者
WOLFF, B
COHEN, G
HAUBER, J
MESHCHERYAKOVA, D
RABECK, C
机构
[1] Sandoz Research Institute, A-1235 Vienna
关键词
D O I
10.1006/excr.1995.1060
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The human immunodeficiency virus type 1 (HIV-1) regulatory protein Rev, which is required for the cytoplasmic expression of unspliced and incompletely spliced viral mRNAs, is located predominantly in the nucleolus. In this study, we show that Rev translocates from the nucleolus to the cytoplasm in HeLa and COS cells transfected with Rev under conditions where rRNA synthesis is inhibited (e.g., with actinomycin D). Dominant-negative mutants with mutations in the activation domain of Rev, which are known to inhibit wildtype Rev function in trans, are unable to leave the nucleus upon actinomycin D treatment. More importantly, when present in excess, these mutants inhibit the translocation of wild-type Rev. This correlation of inhibitory activities suggests that Rev function depends on its transport to and presence (at least transient) in the cytoplasm. In this context, we discuss the possibility that Rev is actively involved in the transport of HIV-1-specific mRNAs containing the Rev response element (a highly structured RNA sequence, which is specifically recognized by the Rev trans-activator). We also discuss the potential of nucleocytoplasmic export of Rev as a target for anti-HIV chemotherapy. (C) 1995 Academic Press, Inc.
引用
收藏
页码:31 / 41
页数:11
相关论文
共 50 条
  • [21] ACTIVATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENHANCER IS NOT DEPENDENT ON NFAT-1
    MARKOVITZ, DM
    HANNIBAL, MC
    SMITH, MJ
    COSSMAN, R
    NABEL, GJ
    JOURNAL OF VIROLOGY, 1992, 66 (06) : 3961 - 3965
  • [22] HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 REV PROTEIN AS A NEGATIVE TRANS-REGULATOR
    SADAIE, MR
    BENAISSA, ZN
    CULLEN, BR
    WONGSTAAL, F
    DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1989, 8 (09): : 669 - 674
  • [23] REV PROTEIN OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 AFFECTS THE STABILITY AND TRANSPORT OF THE VIRAL MESSENGER-RNA
    FELBER, BK
    HADZOPOULOUCLADARAS, M
    CLADARAS, C
    COPELAND, T
    PAVLAKIS, GN
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (05) : 1495 - 1499
  • [24] THE ORIGIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REV GENE - AN EVOLUTIONARY HYPOTHESIS
    KUBOTA, S
    OROSZLAN, S
    HATANAKA, M
    FEBS LETTERS, 1994, 338 (02) : 118 - 121
  • [25] MINIMAL REV-RESPONSE ELEMENT FOR TYPE-1 HUMAN-IMMUNODEFICIENCY-VIRUS
    HUANG, XJ
    HOPE, TJ
    BOND, BL
    MCDONALD, D
    GRAHL, K
    PARSLOW, TG
    JOURNAL OF VIROLOGY, 1991, 65 (04) : 2131 - 2134
  • [26] IDENTIFICATION OF A HIGH-AFFINITY RNA-BINDING SITE FOR THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REV PROTEIN
    TILEY, LS
    MALIM, MH
    TEWARY, HK
    STOCKLEY, PG
    CULLEN, BR
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (02) : 758 - 762
  • [27] THE CYTOTOXICITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REV - IMPLICATIONS FOR ITS INTERACTION WITH THE NUCLEOLAR PROTEIN B23
    MIYAZAKI, Y
    TAKAMATSU, T
    NOSAKA, T
    FUJITA, S
    MARTIN, TE
    HATANAKA, M
    EXPERIMENTAL CELL RESEARCH, 1995, 219 (01) : 93 - 101
  • [28] PROTEIN-PROTEIN INTERACTIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GAG AND CAPSID PROTEINS
    EHRLICH, LS
    AGRESTA, BE
    ZYBARTH, G
    CARTER, C
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 45 - 45
  • [29] DISULFIDE BOND FORMATION IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF PROTEIN
    ZAZOPOULOS, E
    HASELTINE, WA
    JOURNAL OF VIROLOGY, 1993, 67 (03) : 1676 - 1680
  • [30] INTEGRATION IS NOT NECESSARY FOR EXPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEIN PRODUCTS
    STEVENSON, M
    HAGGERTY, S
    LAMONICA, CA
    MEIER, CM
    WELCH, SK
    WASIAK, AJ
    JOURNAL OF VIROLOGY, 1990, 64 (05) : 2421 - 2425